The state authorities of Odisha has requested the Bihar government to extend cooperation in the investigation into supply and sale of spurious hypertension drugs, Telma 40 and Telma AM tablets in Cuttack.
Odisha Health Secretary has asked his Bihar counterpart in a letter to issue concerned authorities to extend their cooperation to a team deputed by Odisha for probe into the case.
A team consisting of Tushar Ranjan Panigrahi, Asst.Drugs Controller and Dharmadev Puhan, Asst.Drugs Controller will proceed to Bihar to obtain details of firm from Drugs Control Administration, Bihar, which is involved in supply of the said spurious drugs, a letter of the Odisha Health Secretary noted.
Notably, Odisha government had earlier asked the Drugs Controller, Bihar on two ocassions to provide the details on supply of drugs made to the State of Odisha, but, no feedback has been received till now.
Thus the State Health Secretary has asked Bihar government to instruct its Drugs Controller to submit the reply to Odisha government at the earliest to expedite the investigation as the matter related to spurious drug must be attended to with utmost urgency in larger public interest.
The Odisha Health department has informed that two drugs Telma 40 Tablet, Batch No. 1811055, DIM- Mar-22, D/E- Feb/25, under Mfg Licence No.- MNB/05/182 a by Glenmark Pharmaceuticals Ltd., At- Village- Kishanapura, Baddi, Dist- SoIan (HP) have been found to be spurious. This apart, Telma AM tablet, Batch No. 18220083, Mfg Dt. Feb, 2022, Exp Dt. January, 2025, claimed to be Mfg by - MIs Glenmark Pharmaceuticals Ltd., Samlik Marchak, Industrial Growth centre, East Sikkim-737135 have also been detected to be duplicate under Section-17B (e) of Drugs & Cosmetics Act based on report received from original manufacturer.
Accordingly, investigation has revealed that the said drugs were supplied to Odisha by a firm named M/s Balaji Drug Point, Jail Press Road, Gaya, Bihar having Drug Licence No, BR-GYU106861, GSTIN No. 10AVWPK9086H1Z1.